Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-06, Stock:PFE, The news for the past five days is as follows:
2018-10-30: NEWS1: Amgen Earnings, Revenue beat in Q3.NEWS2: Business Highlights.NEWS3: After Hours Most Active for Oct 30, 2018 :  PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY.NEWS4: After Hours Most Active for Oct 30, 2018 :  PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY.NEWS5: Dow Closes Sharply Higher as Late Surge Pushes Stock Gains.NEWS6: 5 Things You Might Miss in Pfizer's Q3 Earnings Without Reading the Fine Print.NEWS7: 5 Things You Might Miss in Pfizer's Q3 Earnings Without Reading the Fine Print.NEWS8: Pfizer Stock Dips on Q3 Revenue Miss.NEWS9: Pfizer Stock Dips on Q3 Revenue Miss.NEWS10: Health Care Sector Update for 10/30/2018: AMED,VTGN,PFE,AGN.NEWS11: Health Care Sector Update for 10/30/2018: AMED,VTGN,PFE,AGN.NEWS12: Dow Leads Indexes Higher With Late Surge.NEWS13: Pfizer’s Hospital-Drug Problems Won’t Go Away.NEWS14: 5 Things You Might Miss in Pfizer&apos;s Q3 Earnings Without Reading the Fine Print.NEWS15: Pfizer Missed Analysts’ Third-Quarter Revenue Estimates.NEWS16: Profit for Viagra-maker Pfizer spikes in Q3.NEWS17: Health Care Sector Update for 10/30/2018: AGN,PFE,VTGN.NEWS18: Health Care Sector Update for 10/30/2018: AGN,PFE,VTGN.NEWS19: Pfizer revenue worse than expected as generic competition weighs.NEWS20: Pfizer revenue worse than expected as generic competition weighs.NEWS21: Pfizer revenue worse than expected as generic competition weighs.NEWS22: Pharma&apos;s support of Trump&apos;s drug pricing plan is fraying heading into midterms.NEWS23: Pharma's support of Trump's drug pricing plan is fraying heading into midterms.NEWS24: Dow Rises but Wall Street Wavers Amid Mixed Earnings Reports.NEWS25: Mid-Day Update: Wall Street Recovers as Earnings Lift Market Averages, Trade Tensions Ease.NEWS26: Mid-Day Update: Wall Street Recovers as Earnings Lift Market Averages, Trade Tensions Ease.NEWS27: US STOCKS-Wall Street moves higher as chip stocks rebound.NEWS28: Pfizer's 3Q profit, up due to tax cut, beats expectations.NEWS29: Pfizer's 3Q profit, up due to tax cut, beats expectations.NEWS30: Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View.NEWS31: Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View.NEWS32: Dow Rises Sharply, Stocks Trade Higher Amid Mixed Earnings Reports.NEWS33: Pfizer CEO says tying drug prices to foreign countries is....NEWS34: US STOCKS-Wall Street gains as chip stocks lead bounce back.NEWS35: OEF, PFE, UNH, C: Large Inflows Detected at ETF.NEWS36: OEF, PFE, UNH, C: Large Inflows Detected at ETF.NEWS37: Dow Movers: PFE, INTC.NEWS38: Dow Movers: PFE, INTC.NEWS39: Pfizer’s Lingering Hospira Woes Are Troubling.NEWS40: Bristol-Myers Squibb: All You Need to Know after Its Q3 Results.NEWS41: Understanding Bristol-Myers Squibb’s Operational Performance.NEWS42: What Bristol-Myers Squibb’s Bottom Line Trend Indicates.NEWS43: HCA Earnings, Revenue beat in Q3.NEWS44: Pfizer Stock Dips on Q3 Revenue Miss.NEWS45: Stocks - Coca-Cola, Apple Gain in Pre-market; GE, Pfizer Sink.NEWS46: Stocks Trade Higher as Earnings Reports Are Mixed.NEWS47: Sanofi’s Q3 Estimates: Expect Revenue Growth.NEWS48: Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View.NEWS49: Pfizer CEO designate does not see need for large acquisitions.NEWS50: US STOCKS-U.S. stocks ride higher on trade optimism.NEWS51: Stocks - U.S. Futures Rise As GE, Coca-Cola Report Earnings.NEWS52: Pfizer cuts revenue forecast as supply snags, dollar strength weigh.NEWS53: Pfizer Earnings beat, Revenue misses In Q3.NEWS54: Top 4 Mutual Fund Holders of Pfizer.NEWS55: Pfizer Narrows Forecast as Older Drugs Business Struggles.NEWS56: Stocks struggle to rebound after mixed earnings from Coca-Cola and Pfizer, downbeat housing report.NEWS57: Wall Street Bounces Back as Trump Soothes Trade-War Jitters.NEWS58: Wall Street Bounces Back as Trump Soothes Trade-War Jitters.NEWS59: Health Care Sector Update for 10/30/2018: PFE, AGN, VTGN.NEWS60: Health Care Sector Update for 10/30/2018: PFE, AGN, VTGN.NEWS61: Pfizer (PFE) Q3 Earnings Beat Estimates.NEWS62: Pfizer (PFE) Q3 Earnings Beat Estimates.NEWS63: Dow Gains 91 Points, but Earnings Could Change That.NEWS64: Dow Gains 91 Points, but Earnings Could Change That.NEWS65: Top 5 Things to Know in the Market on Tuesday.NEWS66: US STOCKS-Wall St set to open higher on trade optimism.NEWS67: Pfizer cuts revenue forecast as supply snags, dollar strength weigh.NEWS68: Pfizer (PFE) Q3 Earnings Beat Estimates.NEWS69: Pfizer Tops Q3 Earnings Estimate, Narrows Full-Year Guidance Range.NEWS70: US STOCKS-Futures higher on Trump's optimistic comments on China trade deal.NEWS71: Stocks making the biggest move premarket: KO, GE, PFE, TPR, UAA & more.NEWS72: [$$] Pfizer outlook dented by strong dollar and legacy drug unit.NEWS73: Pfizer's a tan minivan these days and that's a good thing....NEWS74: Pfizer posts mixed third-quarter results, narrows full-year forecast, shares drop.NEWS75: Pfizer&apos;s stock falls after profit beats, but revenue misses.NEWS76: PFIZER REPORTS THIRD-QUARTER 2018 RESULTS.NEWS77: Pfizer posts mixed quarter.NEWS78: Pfizer Q3 18 Earnings Conference Call At 10:00 AM ET.NEWS79: Pfizer Q3 18 Earnings Conference Call At 10:00 AM ET.NEWS80: Pfizer Narrows 2018 Revenues Guidance.NEWS81: Pfizer Narrows 2018 Revenues Guidance.NEWS82: Pfizer Inc. Q3 adjusted earnings Beat Estimates.NEWS83: Pfizer Inc. Q3 adjusted earnings Beat Estimates.NEWS84: European Shares Seen Opening On Steady Note.NEWS85: European Shares Seen Opening On Steady Note.
2018-10-31: NEWS1: Baxter Earnings beat, Revenue misses In Q3.NEWS2: 10 Hot Stocks to Buy Right Now.NEWS3: 10 Hot Stocks to Buy Right Now.NEWS4: Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View.NEWS5: Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View.NEWS6: Big Pharma&apos;s Price Freezes Aren&apos;t Fooling Anybody.NEWS7: How Merck Stands Financially in October.NEWS8: Gauging Analysts’ Views on Bristol-Myers Squibb Stock.NEWS9: Health Care Sector Update for 10/31/2018: CLVS, EXAS, SNY, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Health Care Sector Update for 10/31/2018: CLVS, EXAS, SNY, JNJ, PFE, ABT, MRK, AMGN.NEWS11: A Look at the Performances of BMY’s Established Brands.NEWS12: Today’s Research Reports on Stocks to Watch: Daxor and Pfizer.NEWS13: Analyzing Bristol-Myers Squibb’s Product Performance.NEWS14: ViiV Healthcare Announces Positive Phase 3 Results From BRIGHTE Study.NEWS15: ViiV Healthcare Announces Positive Phase 3 Results From BRIGHTE Study.NEWS16: [$$] Pfizer Narrows Guidance on Tougher Pricing, Generic Competition.
2018-11-01: NEWS1: Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine.NEWS2: Pfizer cut to market perform at BMO.NEWS3: BMO: ‘Significant Headwinds’ Will Cap Pfizer Upside.NEWS4: White House wants to crack down on drug companies before the midterm elections.NEWS5: BMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'.NEWS6: Edited Transcript of PFE earnings conference call or presentation 30-Oct-18 2:00pm GMT.NEWS7: Has Pfizer (PFE) Outpaced Other Medical Stocks This Year?.NEWS8: Here's What Exact Sciences Just Said About Its Future.NEWS9: Here's What Exact Sciences Just Said About Its Future.NEWS10: Zoetis Inc Earnings, Revenue beat in Q3.NEWS11: 3 Pharma Stocks to Make a Portfolio Feel Better.NEWS12: Pfizer weighing sale of women's health portfolio - Bloomberg.NEWS13: Health Care Sector Update for 11/01/2018: TEVA, NVO, SNN, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Health Care Sector Update for 11/01/2018: TEVA, NVO, SNN, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Here&apos;s What Exact Sciences Just Said About Its Future.NEWS16: Pfizer downgraded by BMO: &apos;Significant headwinds&apos; will cap the drugmaker&apos;s stock run.NEWS17: Stocks making the biggest move premarket: DWDP, NFX, ECA, AAPL, CI & more.NEWS18: Pfizer will go back to price hikes ‘as normal’ come January, CEO suggests.
2018-11-02: NEWS1: FDA approves Pfizer's treatment for certain lung cancer patients.NEWS2: Exelixis (EXEL) Q3 Earnings, Revenues Beat on Cabometyx Sales.NEWS3: Exelixis (EXEL) Q3 Earnings, Revenues Beat on Cabometyx Sales.NEWS4: Stocks finish lower after a volatile trading session.NEWS5: U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC.NEWS6: Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO.NEWS7: Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO.NEWS8: Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates.NEWS9: Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates.NEWS10: Here's Why Exelixis Inc. Stock Is Surging Today.NEWS11: Here's Why Exelixis Inc. Stock Is Surging Today.NEWS12: Pfizer’s Earnings Projections for 2018.NEWS13: SQQQ, FTXH: Big ETF Inflows.NEWS14: SQQQ, FTXH: Big ETF Inflows.NEWS15: Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO.NEWS16: Revenue Projections for Pfizer in 2018.NEWS17: What Does Gilead Sciences’ Bottom-Line Trend Indicate?.NEWS18: Gilead Sciences’ Operational Performance.NEWS19: Gilead Sciences: An Update for Investors.NEWS20: AbbVie Earnings, Revenue beat in Q3.NEWS21: Here’s How Pfizer Stock Moved in October.NEWS22: Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus.NEWS23: Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus.NEWS24: Dow 30 Stock Roundup: Apple, Coca-Cola, DowDuPont Earnings Impress.NEWS25: Dow 30 Stock Roundup: Apple, Coca-Cola, DowDuPont Earnings Impress.NEWS26: Report: Exploring Fundamental Drivers Behind Pfizer, eBay, ABM Industries, Quad Graphics, FireEye, and BJ's Restaurants — New Horizons, Emerging Trends, and Upcoming Developments.NEWS27: Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus.NEWS28: Dow 30 Stock Roundup: Apple, Coca-Cola, DowDuPont Earnings Impress.NEWS29: Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine.NEWS30: Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine.
2018-11-05: NEWS1: Biogen Stock Rebounds After Impressive Q3 Earnings.NEWS2: Biogen Stock Rebounds After Impressive Q3 Earnings.NEWS3: Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates.NEWS4: Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates.NEWS5: A Look at Teva Pharmaceutical’s Third-Quarter Earnings.NEWS6: Bulls & Bears Of The Week: Amazon, Apple, Ford, GE And More.NEWS7: Teva Pharmaceutical’s Performance in the Third Quarter.NEWS8: Biogen Stock Rebounds After Impressive Q3 Earnings.NEWS9: Xtandi’s Label Expansion Drives Future Growth.NEWS10: Hedge Funds Are Piling Into This Stock.NEWS11: Health Care Sector Update for 11/05/2018: BTAI, FOLD, TFX, PFE, JNJ, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 11/05/2018: BTAI, FOLD, TFX, PFE, JNJ, ABT, MRK, AMGN.NEWS13: Ibrance: A Key Growth Driver for Pfizer.NEWS14: Gilead Sciences: Analysts’ Recommendations.NEWS15: Analyzing Pfizer’s Expense Projections for 2018.NEWS16: Analyzing Gilead Sciences’ HIV Portfolio.

Answer: Decrease